Summary & Overview

CPT 89049: Caffeine Halothane Contracture Test for Malignant Hyperthermia

Headline: CPT code 89049: Caffeine Halothane Contracture Test for Malignant Hyperthermia Risk

Lead: CPT code 89049 represents the caffeine halothane contracture test (CHCT), a specialized diagnostic laboratory procedure that evaluates a muscle biopsy for susceptibility to malignant hyperthermia (MH). This code covers a high‑impact, low‑volume service essential to perioperative safety and anesthetic planning.

CPT code 89049 denotes a laboratory diagnostic service that determines MH susceptibility by measuring muscle contracture response to caffeine and halothane. Nationally, CHCT is clinically important because it identifies patients at risk for a potentially fatal intraoperative reaction, informing anesthesia choice and perioperative management. The service is typically performed in hospital outpatient laboratories or specialized neuromuscular diagnostic centers and is ordered when clinical history or family history raises concern for MH.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find concise benchmarks and context for CPT code 89049, including typical settings of service, clinical indications, and payer coverage considerations. The publication outlines how this code fits into diagnostic pathways for MH, common documentation elements expected for claims, and national policy patterns affecting coverage and utilization.

What readers will learn: an overview of the clinical role of CHCT, where the service is performed, which major payers cover it, and the types of benchmarks and policy updates that influence coding and reimbursement for this specialized diagnostic test.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareCPT 89049caffeine halothane contracture testmalignant hyperthermiadiagnostic laboratorymuscle biopsyanesthesia safetyperioperative diagnosticslaboratory medicineneuromuscular testing

Billing Code Overview

CPT code 89049 describes a caffeine halothane contracture test (CHCT) performed on a muscle biopsy to evaluate susceptibility to malignant hyperthermia (MH), a life‑threatening reaction to certain anesthetic agents. The procedure involves laboratory analysis of excised skeletal muscle tissue to measure contractile responses to caffeine and halothane, aiding diagnostic confirmation of MH susceptibility.

Service Type: Diagnostic laboratory analysis of muscle biopsy for malignant hyperthermia susceptibility

Typical Site of Service: Hospital outpatient laboratory or specialized clinical laboratory associated with anesthesiology or neuromuscular diagnostic services

Clinical & Coding Specifications

Clinical Context

A 28-year-old patient with a family history of malignant hyperthermia (MH) is referred to a tertiary neuromuscular laboratory after an episode of unexplained hyperthermia during a prior general anesthetic. The surgical team arranges a targeted open or needle muscle biopsy under local or monitored anesthesia care. The biopsy specimen is transported immediately on ice to the specialized laboratory. A clinical laboratory analyst performs the caffeine-halothane contracture test (CHCT, CPT 89049) to assess increased contracture response of skeletal muscle strips to caffeine and halothane, confirming or excluding susceptibility to MH. Results are interpreted in the context of clinical history and, if available, prior genetic testing for RYR1 or CACNA1S variants. The laboratory documents specimen receipt time, muscle viability testing, assay conditions, and numeric contracture responses; the final report is transmitted to the referring anesthesiologist, surgeon, and the patient’s primary care provider. Typical site of service is an outpatient specialized neuromuscular or pathology laboratory or hospital-based clinical laboratory equipped for physiologic contracture testing.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the professional interpretation component if the laboratory separates technical and professional components.

Taxonomy Code	Specialty	Notes
207L00000X	Neurology	Neurologists often coordinate neuromuscular evaluations and referrals for CHCT.
207P00000X	Pathology	Pathologists oversee laboratory processing and interpretation when tests are performed in hospital labs.
208000000X	Anesthesiology	Anesthesiologists request testing for perioperative risk assessment of MH susceptibility.
223Q00000X	Clinical Laboratory	Clinical laboratory specialists and analysts perform the contracture testing and report results.
208U00000X	Pediatric Anesthesiology	Pediatric anesthesiologists may refer children with suspected MH susceptibility for testing.

ICD-10 Code	Description	Clinical Relevance
`T88.3XXA`	Malignant hyperthermia due to anesthesia, initial encounter	Directly documents an MH event prompting CHCT evaluation for susceptibility.
`Z15.01`	Genetic susceptibility to malignant hyperthermia	Used when a patient has known family history or genetic risk warranting confirmatory CHCT.
`G72.89`	Other myopathies	Underlying muscle disease may be evaluated concurrently or considered when interpreting contracture results.
`R65.0`	Systemic inflammatory response syndrome (SIRS) of non-infectious origin	Historical perioperative hypermetabolic events sometimes coded when evaluating MH-like episodes.
`Z13.6`	Encounter for screening for genetic and chromosomal anomalies	Applied when screening family members for MH susceptibility using CHCT as part of risk assessment.

CPT Code	Description	Relationship to This Procedure
`20200`	Biopsy, muscle; superficial	Often performed to obtain the muscle specimen sent to the laboratory for `CPT 89049`.
`20205`	Muscle biopsy, deep	Used when a deeper or open muscle biopsy is required to obtain adequate tissue for CHCT.
`88305`	Level IV surgical pathology, gross and microscopic examination	May apply to histologic evaluation of the biopsy specimen when concurrent pathological analysis is performed.
`80502`	Drug test, amphetamines, other studies (placeholder)	Data not available in the input.
`99000`	Handling and/or conveyance of specimens (non-covered)	Ancillary billing considerations for specimen transport; usage varies by payer.

OpenPayer